Cleared Traditional

PARTNER SEVEN DISP. BUBBLE OXYGENATOR (K800555) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K800555 · Cardiovascular Research, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1980
Decision
23d
Days
Class 2
Risk

K800555 is an FDA 510(k) clearance for the PARTNER SEVEN DISP. BUBBLE OXYGENATOR. Classified as Oxygenator, Cardiopulmonary Bypass (product code DTZ), Class II - Special Controls.

Submitted by Cardiovascular Research, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 4, 1980 after a review of 23 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4350 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cardiovascular Research, Inc. devices

Submission Details

510(k) Number K800555 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 12, 1980
Decision Date April 04, 1980
Days to Decision 23 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
102d faster than avg
Panel avg: 125d · This submission: 23d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DTZ Oxygenator, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4350
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DTZ Oxygenator, Cardiopulmonary Bypass

All 92
Devices cleared under the same product code (DTZ) and FDA review panel - the closest regulatory comparables to K800555.
TERUMO HOLLOW FIBER OXYGENATOR
K812660 · Terumo Medical Corp. · Dec 1981
SHILEY S-100A (ADULT) BLOOD OXYGENATOR
K810470 · Shiley, Inc. · Apr 1981
THB 6000 HARDSHELL BUBBLE OXYGENATOR
K803231 · Travenol Laboratories, S.A. · Jan 1981
WILLIAM HARVEY H-1500 BLOOD OXYGENATOR
K792039 · C.R. Bard, Inc. · Oct 1979
OXYGENATOR, BLOOD, INFANT/PEDIATRIC
K781223 · Shiley, Inc. · Jul 1978
OXYGENATOR, BUBBLE
K772237 · Shiley, Inc. · Dec 1977